by Tony Akiwumi | Nov 18, 2025 | Pharma / Market Access
When the British explorer Ernest Shackleton prepared for his Antarctic expedition, he spent weeks asking one question that his competitors ignored: not “How do we get there fastest?” but “How do we survive if things go wrong?” That single shift in questioning shaped...
by Tony Akiwumi | Nov 18, 2025 | Pharma / Market Access
When NASA investigated the Challenger disaster, one of the most striking details was that several engineers had quietly expressed concern about the O-ring temperatures before the launch. Their curiosity about a seemingly small data anomaly could have changed history...
by Tony Akiwumi | Nov 18, 2025 | Pharma / Market Access
Leading change can feel like trying to convince people to give up their favourite chair — comfortable, familiar, but badly in need of replacing. You can explain the benefits of the new one all you like; until they sit in it and feel it for themselves, resistance...
by Tony Akiwumi | Nov 17, 2025 | Pharma / Market Access
Writing a corporate vision statement is a bit like writing poetry by committee. Everyone wants a line that represents their department, so the end result sounds polished but empty. It’s hard to inspire anyone with a paragraph that could apply to every company on the...
by Tony Akiwumi | Nov 17, 2025 | Pharma / Market Access
Strategy without risk is dull. Risk without a strategy is chaos. The art lies in keeping the two in tension. Think of it like cooking a soufflé: too cautious and it never rises, too bold, and it collapses. The sweet spot lies somewhere in the middle. Most...
